[Combination erythromycin-oleandomycin: favorable bactericidal effect on pathogenic staphylococci].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D004917:Erythromycin / Q000627:therapeutic use*; D008837:Micrococcus / Q000472:pathogenicity* / Q000628:therapy*; D009827:Oleandomycin; D013210:Staphylococcus
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D004917:Erythromycin; D009827:Oleandomycin
ANTIBIOTICS/therapeutic use; ERYTHROMYCIN/therapeutic use; MICROCOCCAL INFECTIONS/therapy
L'association érythromycine-oléandomycine: effet bactéricide favorable sur les staphylocoques pathogènes.